WO2006019300A3 - Formule de composition pour enfants - Google Patents

Formule de composition pour enfants Download PDF

Info

Publication number
WO2006019300A3
WO2006019300A3 PCT/NL2005/000609 NL2005000609W WO2006019300A3 WO 2006019300 A3 WO2006019300 A3 WO 2006019300A3 NL 2005000609 W NL2005000609 W NL 2005000609W WO 2006019300 A3 WO2006019300 A3 WO 2006019300A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
nutritional composition
immune stimulatory
infant nutrition
present
Prior art date
Application number
PCT/NL2005/000609
Other languages
English (en)
Other versions
WO2006019300A2 (fr
Inventor
Christopher Beermann
Guenther Boehm
Bernd Stahl
Original Assignee
Nutricia Nv
Christopher Beermann
Guenther Boehm
Bernd Stahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34926246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2006019300(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv, Christopher Beermann, Guenther Boehm, Bernd Stahl filed Critical Nutricia Nv
Priority to CA002577698A priority Critical patent/CA2577698A1/fr
Priority to NZ553299A priority patent/NZ553299A/en
Priority to BRPI0514498-1A priority patent/BRPI0514498A/pt
Priority to EP05775170A priority patent/EP1781306A2/fr
Priority to AU2005273099A priority patent/AU2005273099B2/en
Priority to US11/573,939 priority patent/US20080125346A1/en
Priority to JP2007527084A priority patent/JP2008510697A/ja
Publication of WO2006019300A2 publication Critical patent/WO2006019300A2/fr
Publication of WO2006019300A3 publication Critical patent/WO2006019300A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)

Abstract

La présente invention concerne une composition nutritive contenant des protéines, des corps gras et des hydrates de carbone; et a) un composé nucléotidique sélectionné dans le groupe constitué d'un acide nucléique, de dérivés d'acides nucléiques, de nucléotides, de polyphosphates de nucléosides, de polynucléotides, de nucléosides, de ribose, de désoxyribose et de dinucléosidpolyphosphates (NpXN); et b) un composant de glycane ou de glycoconjugué non protéique chargé négativement, avec un poids moléculaire compris entre 200 et 20000 daltons. La présente composition nutritionnelle est particulièrement adaptée à l'alimentation d'enfants en bas âge car elle simule les effets protecteurs du lait humain et agit notamment contre les allergies et les infections.
PCT/NL2005/000609 2004-08-20 2005-08-22 Formule de composition pour enfants WO2006019300A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002577698A CA2577698A1 (fr) 2004-08-20 2005-08-22 Formule de composition pour enfants
NZ553299A NZ553299A (en) 2004-08-20 2005-08-22 Immune stimulatory infant formula with nucleotides and a negatively charged glycan or glycoconjugate
BRPI0514498-1A BRPI0514498A (pt) 2004-08-20 2005-08-22 composição nutricional, e, uso da composição nutricional
EP05775170A EP1781306A2 (fr) 2004-08-20 2005-08-22 Aliment infantile à activité immunostimulatrice
AU2005273099A AU2005273099B2 (en) 2004-08-20 2005-08-22 Immune stimulatory infant nutrition
US11/573,939 US20080125346A1 (en) 2004-08-20 2005-08-22 Infant Formula
JP2007527084A JP2008510697A (ja) 2004-08-20 2005-08-22 幼児用人工乳

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04019856.6 2004-08-20
EP04019856A EP1634599A1 (fr) 2004-08-20 2004-08-20 Aliment infantile à activité immunostimulatrice

Publications (2)

Publication Number Publication Date
WO2006019300A2 WO2006019300A2 (fr) 2006-02-23
WO2006019300A3 true WO2006019300A3 (fr) 2006-06-01

Family

ID=34926246

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2005/008999 WO2006018314A2 (fr) 2004-08-20 2005-08-19 Aliment pour nourrissons stimulant le systeme immunitaire
PCT/NL2005/000609 WO2006019300A2 (fr) 2004-08-20 2005-08-22 Formule de composition pour enfants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/008999 WO2006018314A2 (fr) 2004-08-20 2005-08-19 Aliment pour nourrissons stimulant le systeme immunitaire

Country Status (15)

Country Link
US (3) US8114441B2 (fr)
EP (3) EP1634599A1 (fr)
JP (2) JP4965444B2 (fr)
CN (3) CN101766228B (fr)
AT (1) ATE427112T1 (fr)
AU (2) AU2005274266B2 (fr)
BR (2) BRPI0514526A (fr)
CA (2) CA2576042C (fr)
DE (1) DE602005013679D1 (fr)
ES (1) ES2322380T3 (fr)
NZ (2) NZ553248A (fr)
PL (1) PL1781307T3 (fr)
RU (2) RU2426549C2 (fr)
UA (1) UA88918C2 (fr)
WO (2) WO2006018314A2 (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723951A1 (fr) * 2005-04-21 2006-11-22 N.V. Nutricia Supplément nutritionnel avec des oligosaccharides pour une catégorie de patients avec HIV
PT1629850E (pt) 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
EP1888081B1 (fr) 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions contenant des acides gras polyinsaturés et leurs méthodes d'utilisation
EP1776877A1 (fr) 2005-10-21 2007-04-25 N.V. Nutricia Méthode de stimulation de la flore intestinale
WO2008054192A1 (fr) * 2006-11-02 2008-05-08 N.V. Nutricia Utilisation de compositions alimentaires pour éviter des maladies
ES2366034T3 (es) * 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
RU2444210C2 (ru) * 2005-12-23 2012-03-10 Н.В. Нютрисиа Питательные композиции для младенцев, предназначенные для предупреждения ожирения
WO2007096148A1 (fr) * 2006-02-23 2007-08-30 Lipid Nutrition B.V. Immunorégulation
JP4610499B2 (ja) * 2006-02-27 2011-01-12 ポーラ化成工業株式会社 食品組成物
WO2007114683A1 (fr) 2006-03-30 2007-10-11 N.V. Nutricia Oligosaccharides de lait destinés à stimuler le système immunitaire
CN101795579A (zh) 2006-08-04 2010-08-04 Shs国际有限公司 无蛋白配方
US20080145506A1 (en) * 2006-12-18 2008-06-19 Bodybio, Inc. Food compositions and products containing balanced ratio of essential fatty acids
WO2008111832A1 (fr) * 2007-03-13 2008-09-18 N.V. Nutricia Procédé permettant d'améliorer des aptitudes avec une composition comprenant un saccharide non digestible
WO2008115046A1 (fr) * 2007-03-22 2008-09-25 N.V. Nutricia Nutrition infantile à base de céréales, avec fibres
WO2008144145A1 (fr) * 2007-05-18 2008-11-27 Mead Johnson Nutrition Company Supplément liquide acidifié pour du lait maternel
EP3263120A1 (fr) * 2007-09-17 2018-01-03 N.V. Nutricia Formulation nutritionnelle ayant une teneur énergétique élevée
US10251899B2 (en) * 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
US20110009349A1 (en) 2007-10-19 2011-01-13 Fonterra Co-Operative Group Limited Methods of maintaining or increasing growth or cognitive development
MX2010004820A (es) * 2007-11-01 2010-08-10 Enzymotec Ltd Mezcla lipidica para nutricion infantil.
WO2009057994A1 (fr) * 2007-11-02 2009-05-07 N.V. Nutricia Dosage unitaire pour la santé cérébrale
WO2009075564A1 (fr) * 2007-12-10 2009-06-18 N.V. Nutricia Mélange de fibres pédiatriques
JP5979816B2 (ja) * 2008-01-04 2016-08-31 ネステク ソシエテ アノニム 不飽和脂肪酸及び酸化窒素放出化合物を含む組成物、並びに認知機能及び関連の機能を高めるためのそれらの使用
EP2130440A1 (fr) * 2008-06-06 2009-12-09 N.V. Nutricia Inhibition de croissance E. Sakazakii
CA2749254A1 (fr) * 2009-01-19 2010-07-22 Catherine Mace Composition alimentaire pour nourrisson
WO2010110649A1 (fr) * 2009-03-24 2010-09-30 N.V. Nutricia Préparation pour nourrisson de 1er âge et 2ème âge
WO2010147456A1 (fr) * 2009-06-19 2010-12-23 N.V. Nutricia Inhibition de la réplication du virus à médiation par nfk-b avec oligosaccharides spécifiques
CA2787318A1 (fr) * 2010-01-21 2011-07-28 Paul Bradley Addis Composition pour accident vasculaire cerebral perinatal et neonatal
NZ623342A (en) 2010-04-26 2014-12-24 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora
JP5996837B2 (ja) * 2010-05-28 2016-09-21 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
CN101978841B (zh) * 2010-08-31 2013-04-10 浙江贝因美科工贸股份有限公司 一种抗蛋白过敏及营养婴儿配方奶粉
WO2012044155A1 (fr) * 2010-09-28 2012-04-05 N.V. Nutricia Composition lipidique utilisée pour programmer une réponse immunitaire
EP2465507A1 (fr) * 2010-11-23 2012-06-20 Nestec S.A. Composition comportant des oligosaccharides pour le traitement des maladies de la peau
DK2498628T3 (da) 2010-12-29 2014-06-23 Abbott Lab Produkter til at formindske forekomsten af nekrotiserende enterocolitis, kolik og korttarmsyndrom hos et spædbarn, en tumling eller et barn
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
EP2658547A1 (fr) 2010-12-31 2013-11-06 Abbott Laboratories Méthodes visant à diminuer la fréquence de l'entérocolite nécrosante chez les nourrissons, les jeunes enfants ou les enfants à l'aide d'oligosaccharides du lait humain
NZ612472A (en) * 2010-12-31 2015-02-27 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX355424B (es) 2010-12-31 2018-04-18 Abbott Lab Oligosacáridos de leche humana para modular la inflamación.
CA2822664C (fr) 2010-12-31 2021-07-20 Abbott Laboratories Formulations nutritionnelles a base d'oligosaccharides de lait humain et d'antioxydants et leurs utilisations
MX355780B (es) 2010-12-31 2018-04-30 Abbott Lab Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
CA2822495C (fr) 2010-12-31 2020-12-22 Abbott Laboratories Methodes d'utilisation d'oligosaccharides du lait humain afin d'ameliorer la sante respiratoire des voies aeriennes
US8795746B2 (en) * 2011-02-16 2014-08-05 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
FI124323B (fi) 2011-02-18 2014-06-30 Valio Oy Maitopohjainen tuote ja menetelmä sen valmistamiseksi
JP5837315B2 (ja) * 2011-03-25 2015-12-24 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
WO2012133198A1 (fr) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 Composition nutritionnelle pour maladies inflammatoires
WO2012177118A1 (fr) 2011-06-22 2012-12-27 N.V. Nutricia Méthode permettant de limiter la survenue d'infections chez le jeune enfant
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
PL2988617T3 (pl) 2013-03-27 2024-02-19 Nutritional Growth Solutions Ltd Suplement odżywczy do poprawy wzrostu
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
DE202013008190U1 (de) 2013-09-17 2013-12-05 Pg Naturpharma Gmbh Zubereitung und deren Verwendung bei atopischer Dermatitis
EP2857410A1 (fr) * 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Procédé de purification de 2´-fucosyllactose utilisant la chromatographie à lit mobile simulé
RU2697650C1 (ru) * 2013-11-15 2019-08-16 Сосьете Де Продюи Нестле С.А. Композиции для профилактики или лечения аллергий у младенцев, рожденных или вскармливаемых матерями несекреторного типа, путем обеспечения фукозилированными олигосахаридами, в частности среди младенцев, подверженных риску или рожденных с помощью кесарева сечения
US20150157048A1 (en) * 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
WO2015154257A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
WO2015154263A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles synthétiques spécifiques du sexe et systèmes nutritionnels les comprenant
WO2015154260A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles synthétiques spécifiques du sexe et systèmes nutritionnels les comprenant
WO2015154254A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
WO2015154251A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
WO2015154265A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. <u />COMPOSITIONS NUTRITIONNELLES SYNTHÉTIQUES SPÉCIFIQUES DU SEXE ET SYSTÈMES NUTRITIONNELS LES COMPRENANT
WO2015154256A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles synthétiques spécifiques du sexe et systèmes nutritionnels les comprenant
WO2015154259A1 (fr) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Compositions nutritionnelles de synthèse sexospécifiques et systèmes nutritionnels les comprenant
MY186844A (en) 2014-07-09 2021-08-25 Cadena Bio Inc Oligosaccharide compositions and methods for producing thereof
FR3029114B1 (fr) * 2014-12-01 2017-01-13 United Pharmaceuticals Composition nutritionnelle infantile dans le traitement de la dermatite atopique et de ses symptomes
JP6722697B2 (ja) 2015-01-26 2020-07-15 カデナ・バイオ・インコーポレイテッド 動物飼料として使用するためのオリゴ糖組成物及びその生成方法
PT3354282T (pt) 2015-01-26 2021-03-18 Kaleido Biosciences Inc Produtos terapêuticos de glicanos e seus métodos relacionados
CA2983236A1 (fr) * 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Agents therapeutiques de glycanes et procedes de traitement
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
CN105231461A (zh) * 2015-10-30 2016-01-13 中营康园（北京）科技有限公司 一种提高机体免疫力的营养组合物及其应用
ES2638195B1 (es) 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN112933104B (zh) * 2021-02-02 2021-12-14 陈玉松 核苷酸的新用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0483070A2 (fr) * 1990-10-24 1992-04-29 Sandoz Nutrition Ltd. Aliment complet contenant des fibres solubles hydrolysées
EP0756828A1 (fr) * 1995-08-04 1997-02-05 N.V. Nutricia Composition nutritionnelle contenant des fibres diététiques
AU2263800A (en) * 1987-05-29 2000-06-08 Abbott Laboratories Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation
US20030054083A1 (en) * 2000-12-13 2003-03-20 Sharon Gohman Infant formula with free amino acids and nucleotides
US20030060445A1 (en) * 2000-02-17 2003-03-27 Wilson Jeffrey L. Nutritional formulation containing prebiotic substances

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61192245A (ja) * 1985-02-21 1986-08-26 Snow Brand Milk Prod Co Ltd アルギニン配合粉乳
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
KR100321543B1 (ko) 1991-01-24 2002-09-12 마르텍 코포레이션 미생물-기원오일혼합물및이의용도
US5472952A (en) 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
DE4344342C2 (de) * 1993-12-23 1996-08-08 Milupa Ag Molkenprotein-dominante Säuglingsnahrung
JP3419897B2 (ja) * 1994-07-22 2003-06-23 明治乳業株式会社 低アレルギー性調製乳
JP4034364B2 (ja) * 1994-10-11 2008-01-16 雪印乳業株式会社 抗アレルギー剤
US5792501A (en) * 1996-04-15 1998-08-11 The Iams Company Queen's milk replacer
US5780081A (en) * 1996-10-28 1998-07-14 Nestec S.A. Fortification of food with calcium and process of making
JPH10262607A (ja) * 1997-03-28 1998-10-06 Snow Brand Milk Prod Co Ltd 乳幼児用栄養組成物
DK0996732T3 (da) 1997-04-11 2005-10-17 Calgene Llc Fremgangsmåder og sammensætninger til syntese af langkædede polyumættede fedtsyrer i planter
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6245379B1 (en) * 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
US6777391B1 (en) * 1999-04-29 2004-08-17 Nestec S.A. Composition for an infant formula having a low threonine content
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US20040143013A1 (en) 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6623954B1 (en) 2002-05-28 2003-09-23 Neose Technologies, Inc. Process for removal of phosphorous from a dairy stream
DE60327211D1 (de) 2002-06-28 2009-05-28 Glykos Finland Oy Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
DK1721612T3 (da) 2003-10-24 2009-06-02 Nutricia Nv Immunmodulerende oligosaccharider

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2263800A (en) * 1987-05-29 2000-06-08 Abbott Laboratories Nourishing products enriched with nucleosides and/or nucleotides for infants and adults and processes for their preparation
EP0483070A2 (fr) * 1990-10-24 1992-04-29 Sandoz Nutrition Ltd. Aliment complet contenant des fibres solubles hydrolysées
EP0756828A1 (fr) * 1995-08-04 1997-02-05 N.V. Nutricia Composition nutritionnelle contenant des fibres diététiques
US20030060445A1 (en) * 2000-02-17 2003-03-27 Wilson Jeffrey L. Nutritional formulation containing prebiotic substances
US20030054083A1 (en) * 2000-12-13 2003-03-20 Sharon Gohman Infant formula with free amino acids and nucleotides

Also Published As

Publication number Publication date
JP2008510689A (ja) 2008-04-10
US20120195975A1 (en) 2012-08-02
AU2005274266B2 (en) 2011-03-10
WO2006019300A2 (fr) 2006-02-23
CA2577698A1 (fr) 2006-02-23
US8114441B2 (en) 2012-02-14
CN101766228A (zh) 2010-07-07
EP1781307A2 (fr) 2007-05-09
WO2006018314A3 (fr) 2006-06-29
CN101766228B (zh) 2013-05-08
EP1781307B1 (fr) 2009-04-01
EP1781306A2 (fr) 2007-05-09
UA88918C2 (ru) 2009-12-10
AU2005273099B2 (en) 2011-08-18
EP1634599A1 (fr) 2006-03-15
ATE427112T1 (de) 2009-04-15
RU2404785C2 (ru) 2010-11-27
BRPI0514526A (pt) 2008-06-10
CA2576042C (fr) 2017-07-04
CA2576042A1 (fr) 2006-02-23
US20100136134A1 (en) 2010-06-03
PL1781307T3 (pl) 2009-08-31
NZ553299A (en) 2010-09-30
NZ553248A (en) 2009-12-24
RU2426549C2 (ru) 2011-08-20
US8580316B2 (en) 2013-11-12
AU2005274266A1 (en) 2006-02-23
JP4965444B2 (ja) 2012-07-04
CN101048167A (zh) 2007-10-03
RU2007110174A (ru) 2008-09-27
BRPI0514498A (pt) 2008-06-10
WO2006018314A2 (fr) 2006-02-23
JP2008510697A (ja) 2008-04-10
AU2005273099A1 (en) 2006-02-23
CN101039686A (zh) 2007-09-19
ES2322380T3 (es) 2009-06-19
US20080125346A1 (en) 2008-05-29
DE602005013679D1 (de) 2009-05-14
RU2007110173A (ru) 2008-09-27

Similar Documents

Publication Publication Date Title
WO2006019300A3 (fr) Formule de composition pour enfants
EP0739169A1 (fr) Methode de renforcement du systeme immunitaire humain
EP1613169A1 (fr) Compositions et procedes relatifs a des preparations enterales contenant de l&#39;acide sialique
EP1811868A2 (fr) Preparations et methodes de formulation poour formules enteriques contenant de l acide sialique
WO2008033520A3 (fr) Séquences géniques de bifidobactéries et leur utilisation
PL1808442T3 (pl) Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne
BR112012026906A2 (pt) método para obtenção de produtos nutritivos à base de leguminosas
CA2723564C (fr) Acide sialique pour soutenir le systeme immunitaire des personnes agees
WO2007047675A3 (fr) Acides nucleiques et proteines associes a la synthese de galactomannan dans le cafe
Castro-Osses et al. Functional diets modulate the acute phase protein response in Oncorhynchus mykiss subjected to chronic stress and challenged with Vibrio anguillarum
DK0739207T3 (da) Enteral formulering med ribonucleotider
Mateo et al. Effects of supplemental nucleosides for newly weaned pigs
JP4869176B2 (ja) ピリミジン系ヌクレオチド高含有酵母エキス及びその製造方法
WO2007108071A1 (fr) Composition anti-stress et aliment et boisson contenant celle-ci
WO2006058796A3 (fr) Procede pour preparer un substrat enzymatique des analogues de substrat utiles en tant qu&#39;inhibiteurs d&#39;heptosyl-transferases bacteriennes et applications biologiques des inhibiteurs
ES2341163B1 (es) Composiciones inmunoestimulantes.
AU2016102470A4 (en) Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
da Silva et al. Gut microbiota is associated with metabolic health in children with obesity
Kemsley Unraveling breast milk
Choe et al. Purification of macrophage phagocytic activity-enhancing component from ethanol-acetic acid extract of Korean wheat
Rahmawati et al. Protein Mass and Calcium Mass of Broiler Chicken with Added Nucleotides at Different Maintenance Temperatures
Gerichhausen et al. Ucleoside Analyses of Human Milk at 4 Stages of Lactation
AU2009245789C1 (en) Sialic acid to support the immune system in the elderly
Tuohy Modulating the structure and function of the human gut microbiota through diet: a metagenomics insight
Flynn Micronutrients in milk and milk-based food products: edited by E. Renner, Elsevier, 1989,£ 48.00 (xii+ 311 pages) ISBN 1 85166 309 6

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2005273099

Country of ref document: AU

Ref document number: 2005775170

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007527084

Country of ref document: JP

Ref document number: 553299

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2577698

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1672/DELNP/2007

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2005273099

Country of ref document: AU

Date of ref document: 20050822

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1200700585

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 2007110173

Country of ref document: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 200580035168.5

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2005775170

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11573939

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0514498

Country of ref document: BR